Denmark In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!

Denmark In Vitro Diagnostics Market Outlook to 2017- Clinical
Chemistry Genetic Testing, Haematology, Histology and Cytology,
Immuno Chemistry, Infectious Immunology and Microbiology
Culture
Published on December 2011

Report Summary

Denmark In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology,
Immuno Chemistry, Infectious Immunology and Microbiology Culture

Summary

GlobalData's new report, 'Denmark In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology,
Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture' provides key market data on the
Denmark In Vitro Diagnostics market. The report provides value (USD million) for each segment and sub-segment within seven
market categories ' Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious
Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the
aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with
information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house
analysis by GlobalData's team of industry experts.

Scope

- Market size and company share data for In Vitro Diagnostics market categories ' Clinical Chemistry, Genetic Testing, Haematology,
Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.
- Annualized market revenues (USD million) data for each of the segments and sub-segments within seven market categories. Data
from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the Denmark In Vitro Diagnosticsmarket.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, Ortho-Clinical Diagnostics Inc.,
Beckman Coulter, Inc., bioMerieux S.A. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Denmark In Vitro Diagnostics competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution ' Identify, understand and
capitalize.

Denmark In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology Page 1/11
and Microbiology Culture (From Slideshare)


Table of Content

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 12
2 Introduction 15
2.1 What is This Report About' 15
3 In Vitro Diagnostics In Denmark 16
3.1 In Vitro Diagnostics, Market Segmentation 16
3.2 In Vitro Diagnostics, Denmark, Overall Revenue ($m), USD Actual, 2003-2017 17
3.3 In Vitro Diagnostics Market, Denmark, Revenue Mix ($m), 2010 19
3.4 In Vitro Diagnostics Market, Denmark, Category Contribution (%), 2010 20
3.5 In Vitro Diagnostics, Denmark, Company share (2009-2010) 27
4 Clinical Chemistry In Denmark 29
4.1 Clinical Chemistry, Market Segmentation 29
4.2 Clinical Chemistry Market, Denmark, Revenue Mix ($m), 2010 30
4.3 Clinical Chemistry Market, Denmark, Segment Contribution (%), 2010 31
4.4 Clinical Chemistry Overall Revenue (2003-2017) 32
4.4.1 Clinical Chemisty Analyzers Revenue (2003-2017) 36
4.4.2 Urine Analysis Revenue (2003-2017) 40
4.5 Clinical Chemistry Distribution Share (2009-2010) 44
4.6 Clinical Chemistry, Denmark, Company share (2009-2010) 45
5 Genetic Testing In Denmark 47
5.1 Genetic Testing, Market Segmentation 47
5.2 Genetic Testing Market, Denmark, Revenue Mix ($m), 2010 48
5.3 Genetic Testing Market, Denmark, Segment Contribution (%), 2010 49
5.4 Genetic Testing Overall Revenue (2003-2017) 50
5.5 Genetic Testing Distribution Share (2009-2010) 54
5.6 Genetic Testing, Denmark, Company share (2009-2010) 55
6 Haematology In Denmark 57
6.1 Haematology, Market Segmentation 57
6.2 Haematology Market, Denmark, Revenue Mix ($m), 2010 58
6.3 Haematology Market, Denmark, Segment Contribution (%), 2010 59
6.4 Haematology Overall Revenue (2003-2017) 60
6.4.1 Haematology Reagents Revenue (2003-2017) 64
6.4.2 Immunohaematology Revenue (2003-2017) 68
6.4.3 Haemostasis Revenue (2003-2017) 72
6.4.4 Haematology Rapid Tests Revenue (2003-2017) 76
6.4.5 Haematology Cell Counters Revenue (2003-2017) 80
6.5 Haematology Distribution Share (2009-2010) 84
6.6 Haematology, Denmark, Company share (2009-2010) 85
7 Histology And Cytology In Denmark 87
7.1 Histology And Cytology, Market Segmentation 87



7.2 Histology And Cytology Market, Denmark, Revenue Mix ($m), 2010 88
7.3 Histology And Cytology Market, Denmark, Segment Contribution (%), 2010 89
7.4 Histology And Cytology Overall Revenue (2003-2017) 90
7.5 Histology And Cytology Distribution Share (2009-2010) 94
7.6 Histology And Cytology, Denmark, Company share (2009-2010) 95
8 Immuno Chemistry In Denmark 97
8.1 Immuno Chemistry Market, Denmark, Revenue Mix ($m), 2010 97
8.2 Immuno Chemistry Market, Denmark, Segment Contribution (%), 2010 98
8.3 Immuno Chemistry Overall Revenue (2003-2017) 100
8.3.1 Disease Specific Immunochemistry Revenue (2003-2017) 104
8.3.2 Drugs of Abuse / Toxicology Revenue (2003-2017) 108
8.3.3 Endocrinology Tests Revenue (2003-2017) 112
8.3.4 Therapeutic Drug Monitoring Revenue (2003-2017) 116
8.3.5 Immunochemistry Analyzers Revenue (2003-2017) 120
8.4 Immuno Chemistry Distribution Share (2009-2010) 124
8.5 Immuno Chemistry, Denmark, Company share (2009-2010) 125
9 Infectious Immunology In Denmark 127
9.1 Infectious Immunology, Market Segmentation 127
9.2 Infectious Immunology Market, Denmark, Revenue Mix ($m), 2010 128
9.3 Infectious Immunology Market, Denmark, Segment Contribution (%), 2010 129
9.4 Infectious Immunology Overall Revenue (2003-2017) 130
9.5 Infectious Immunology Distribution Share (2009-2010) 134
9.6 Infectious Immunology, Denmark, Company share (2009-2010) 135
10 Microbiology Culture In Denmark 137
10.1 Microbiology Culture, Market Segmentation 137
10.2 Microbiology Culture Market, Denmark, Revenue Mix ($m), 2010 138
10.3 Microbiology Culture Market, Denmark, Segment Contribution (%), 2010 139
10.4 Microbiology Culture Overall Revenue (2003-2017) 140
10.4.1 Microbiology Analyzers Revenue (2003-2017) 144
10.5 Microbiology Culture Distribution Share (2009-2010) 148
10.6 Microbiology Culture, Denmark, Company share (2009-2010) 149
11 Overview of Key Companies in Denmark In Vitro Diagnostics Market 151
11.1 F. Hoffmann-La Roche Ltd. 151
11.1.1 Company Overview 151
11.1.2 Share in the Denmark In Vitro Diagnostics Market 151
11.2 Siemens Healthcare 152
11.3 Abbott Laboratories 153
11.4 Ortho-Clinical Diagnostics Inc. 154
11.5 Beckman Coulter, Inc. 155
11.6 bioMerieux S.A. 156



11.7 Becton, Dickinson and Company 157
11.8 Bio-Rad Laboratories, Inc. 157
11.9 Sysmex Corporation 157
11.10 Mindray Medical International Limited 158
11.11 Alere Inc. 158
11.12 DiaSorin S.p.A 158
11.13 Qiagen N.V. 159
11.14 BioPorto Diagnostics A/S 159
11.15 Phadia AB 159
11.16 Gen-Probe Incorporated 160
11.17 DIAGNOSTICA STAGO, Inc. 160
11.18 PerkinElmer, Inc. 161
11.19 Thermo Fisher Scientific Inc. 161
11.20 HORIBA, Ltd. 162
11.21 Grifols, S.A. 162
11.22 Hologic, Inc. 163
11.23 Immucor, Inc. 163
11.24 Life Technologies Corporation 164
11.25 BioPorto Diagnostics A/S 164
12 In Vitro Diagnostics Market Pipeline Products 165
12.1 Clinical Chemisty Market Pipeline Products 165
12.2 Immuno Chemistry Market Pipeline Products 168
12.3 Haematology Market Pipeline Products 171
12.4 Infectious Immunology Market Pipeline Products 173
12.5 Microbiology Culture Market Pipeline Products 177
12.6 Histology and Cytology Market Pipeline Products 178
12.7 Genetic Testing Market Pipeline Products 179



13 Financial Deals Landscape 183
13.1 Partnerships 183
13.1.1 Dako Enters Into Co-Development Agreement With Bristol-Myers 183
13.1.2 Atonomics Enters Into An Agreement With Beckman Coulter 184
13.1.3 Genmab Enters Into Research Collaboration With Seattle Genetics 185
13.1.4 Biofortuna Enters Into Distribution Agreement with Abbott 186
13.1.5 Dako Denmark Enters Into Co-Development Agreement with Epitomics 187
13.1.6 Genomic Expression Enters Into an Agreement with Copenhagen University, Beijing Genome Institute and Bavarian Nordic
188
13.1.7 BioPorto Enters Into Licensing Agreement with Instrumentation Laboratory 189
13.1.8 Trinity Biotech Enters Into Distribution Agreement with A. Menarini Diagnostics 190
14 Recent Developments 191
14.1 Strategy And Business Planning 191
14.1.1 Aug 25, 2011: Novo Nordisk To Build New Corporate Center In Bagsvaerd, Denmark 191
14.2 Legal and Regulatory 191
14.2.1 Oct 07, 2011: Exiqon Completes Litigation Against Santaris Pharma 191
14.2.2 May 11, 2011: Dako Files Patent Infringement Lawsuit Against Leica In US 192
15 Appendix 193
15.1 Definitions of Markets Covered in the Report 194
15.1.1 In Vitro Diagnostics 194
15.2 Research Methodology 205
15.3 Secondary Research 205
15.4 Primary Research 205
15.5 Models 206
15.6 Forecasts 207
15.7 Expert Panels 207
15.8 GlobalData Consulting 207
15.9 Currency Conversion 208
15.10 Contact Us 208
15.11 Disclaimer 208

List of Tables

Table 1: In Vitro Diagnostics, Denmark, Overall Revenue ($m), USD Actual, 2003-2017 18
Table 2: In Vitro Diagnostics Market, Denmark, Category Contribution (%), 2010 20
Table 3: In Vitro Diagnostics, Australia, Cross-Category Analysis, 2003-2017 22
Table 4: In Vitro Diagnostics, Denmark, Overall Revenue ($m), USD Actual, Historic, 2003-2010 24
Table 5: In Vitro Diagnostics, Denmark, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 26
Table 6: In Vitro Diagnostics, Denmark, Company share by Revenue ($m), USD Actual, 2009-2010 28
Table 7: Clinical Chemistry Market, Denmark, Segment Contribution (%), 2010 31
Table 8: Clinical Chemistry, Denmark, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 33
Table 9: Clinical Chemistry, Denmark, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 35
Table 10: Clinical Chemisty Analyzers, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 37
Table 11: Clinical Chemisty Analyzers, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 39
Table 12: Urine Analysis, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 41
Table 13: Urine Analysis, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 43
Table 14: Clinical Chemistry, Denmark, Distribution Share by Revenue ($m), USD Actual, 2009-2010 44
Table 15: Clinical Chemistry, Denmark, Company share by Revenue ($m), USD Actual 2009-2010 46



Table 16: Genetic Testing Market, Denmark, Segment Contribution (%), 2010 49
Table 17: Genetic Testing, Denmark, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 51
Table 18: Genetic Testing, Denmark, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 53
Table 19: Genetic Testing, Denmark, Distribution Share by Revenue ($m), USD Actual, 2009-2010 54
Table 20: Genetic Testing, Denmark, Company share by Revenue ($m), USD Actual 2009-2010 56
Table 21: Haematology Market, Denmark, Segment Contribution (%), 2010 59
Table 22: Haematology, Denmark, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 61
Table 23: Haematology, Denmark, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 63
Table 24: Haematology Reagents, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 65
Table 25: Haematology Reagents, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 67
Table 26: Immunohaematology, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 69
Table 27: Immunohaematology, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 71
Table 28: Haemostasis, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 73
Table 29: Haemostasis, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 75
Table 30: Haematology Rapid Tests, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 77
Table 31: Haematology Rapid Tests, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 79
Table 32: Haematology Cell Counters, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 81
Table 33: Haematology Cell Counters, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 83
Table 34: Haematology, Denmark, Distribution Share by Revenue ($m), USD Actual, 2009-2010 84
Table 35: Haematology, Denmark, Company share by Revenue ($m), USD Actual 2009-2010 86
Table 36: Histology And Cytology Market, Denmark, Segment Contribution (%), 2010 89
Table 37: Histology And Cytology, Denmark, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 91
Table 38: Histology And Cytology, Denmark, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 93
Table 39: Histology And Cytology, Denmark, Distribution Share by Revenue ($m), USD Actual, 2009-2010 94
Table 40: Histology And Cytology, Denmark, Company share by Revenue ($m), USD Actual 2009-2010 96
Table 41: Immuno Chemistry Market, Denmark, Segment Contribution (%), 2010 98
Table 42: Immuno Chemistry, Denmark, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 101
Table 43: Immuno Chemistry, Denmark, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 103
Table 44: Disease Specific Immunochemistry, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 105
Table 45: Disease Specific Immunochemistry, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 107
Table 46: Drugs of Abuse / Toxicology, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 109
Table 47: Drugs of Abuse / Toxicology, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 111
Table 48: Endocrinology Tests, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 113
Table 49: Endocrinology Tests, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 115
Table 50: Therapeutic Drug Monitoring, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 117
Table 51: Therapeutic Drug Monitoring, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 119
Table 52: Immunochemistry Analyzers, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 121
Table 53: Immunochemistry Analyzers, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 123
Table 54: Immuno Chemistry, Denmark, Distribution Share by Revenue ($m), USD Actual, 2009-2010 124
Table 55: Immuno Chemistry, Denmark, Company share by Revenue ($m), USD Actual 2009-2010 126
Table 56: Infectious Immunology Market, Denmark, Segment Contribution (%), 2010 129
Table 57: Infectious Immunology, Denmark, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 131
Table 58: Infectious Immunology, Denmark, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 133
Table 59: Infectious Immunology, Denmark, Distribution Share by Revenue ($m), USD Actual, 2009-2010 134
Table 60: Infectious Immunology, Denmark, Company share by Revenue ($m), USD Actual 2009-2010 136
Table 61: Microbiology Culture Market, Denmark, Segment Contribution (%), 2010 139
Table 62: Microbiology Culture, Denmark, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 141
Table 63: Microbiology Culture, Denmark, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 143



Table 64: Microbiology Analyzers, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 145
Table 65: Microbiology Analyzers, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 147
Table 66: Microbiology Culture, Denmark, Distribution Share by Revenue ($m), USD Actual, 2009-2010 148
Table 67: Microbiology Culture, Denmark, Company share by Revenue ($m), USD Actual 2009-2010 150
Table 68: Clinical Chemisty Market Pipeline Products 165
Table 69: Immuno Chemistry Market Pipeline Products 168
Table 70: Haematology Market Pipeline Products 171
Table 71: Infectious Immunology Market Pipeline Products 173
Table 72: Microbiology Culture Market Pipeline Products 177
Table 73: Histology and Cytology Market Pipeline Products 178
Table 74: Genetic Testing Market Pipeline Products 179
Table 75: Dako Enters Into Co-Development Agreement With Bristol-Myers 183
Table 76: Atonomics Enters Into An Agreement With Beckman Coulter 184
Table 77: Genmab Enters Into Research Collaboration With Seattle Genetics 185
Table 78: Biofortuna Enters Into Distribution Agreement With Abbott 186
Table 79: Dako Denmark Enters Into Co-Development Agreement With Epitomics 187
Table 80: Genomic Expression Enters Into An Agreement With Copenhagen University, Beijing Genome Institute And Bavarian
Nordic 188
Table 81: BioPorto Enters Into Licensing Agreement With Instrumentation Laboratory 189
Table 82: Trinity Biotech Enters Into Distribution Agreement With A. Menarini Diagnostics 190
Table 83: USD to Local Currency, Denmark, Average Actual Rate 2003-2010 208

List of Figures

Figure 1: In Vitro Diagnostics, Market Segmentation 16
Figure 2: In Vitro Diagnostics, Denmark, Overall Revenue ($m), USD Actual, 2003-2017 17
Figure 3: In Vitro Diagnostics Market, Denmark, Revenue Mix ($m), 2010 19
Figure 4: In Vitro Diagnostics Market, Denmark, Category Contribution (%), 2010 20
Figure 5: In Vitro Diagnostics, Denmark, Cross-Category Analysis, 2003-2017 21
Figure 6: In Vitro Diagnostics, Denmark, Overall Revenue ($m), USD Actual, Historic, 2003-2010 23
Figure 7: In Vitro Diagnostics, Denmark, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 25
Figure 8: In Vitro Diagnostics, Denmark, Company share (%), 2010 27
Figure 9: Clinical Chemistry, Market Segmentation 29
Figure 10: Clinical Chemistry Market, Denmark, Revenue Mix ($m), 2010 30
Figure 11: Clinical Chemistry Market, Denmark, Segment Contribution (%), 2010 31
Figure 12: Clinical Chemistry, Denmark, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 32
Figure 13: Clinical Chemistry, Denmark, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 34
Figure 14: Clinical Chemisty Analyzers, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 36
Figure 15: Clinical Chemisty Analyzers, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 38
Figure 16: Urine Analysis, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 40
Figure 17: Urine Analysis, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 42
Figure 18: Clinical Chemistry, Denmark, Company share (%), 2010 45
Figure 19: Genetic Testing, Market Segmentation 47
Figure 20: Genetic Testing Market, Denmark, Revenue Mix ($m), 2010 48
Figure 21: Genetic Testing Market, Denmark, Segment Contribution (%), 2010 49
Figure 22: Genetic Testing, Denmark, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 50
Figure 23: Genetic Testing, Denmark, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 52
Figure 24: Genetic Testing, Denmark, Company share (%), 2010 55



Figure 25: Haematology, Market Segmentation 57
Figure 26: Haematology Market, Denmark, Revenue Mix ($m), 2010 58
Figure 27: Haematology Market, Denmark, Segment Contribution (%), 2010 59
Figure 28: Haematology, Denmark, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 60
Figure 29: Haematology, Denmark, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 62
Figure 30: Haematology Reagents, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 64
Figure 31: Haematology Reagents, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 66
Figure 32: Immunohaematology, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 68
Figure 33: Immunohaematology, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 70
Figure 34: Haemostasis, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 72
Figure 35: Haemostasis, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 74
Figure 36: Haematology Rapid Tests, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 76
Figure 37: Haematology Rapid Tests, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 78
Figure 38: Haematology Cell Counters, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 80
Figure 39: Haematology Cell Counters, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 82
Figure 40: Haematology, Denmark, Company share (%), 2010 85
Figure 41: Histology And Cytology, Market Segmentation 87
Figure 42: Histology And Cytology Market, Denmark, Revenue Mix ($m), 2010 88
Figure 43: Histology And Cytology Market, Denmark, Segment Contribution (%), 2010 89
Figure 44: Histology And Cytology, Denmark, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 90
Figure 45: Histology And Cytology, Denmark, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 92
Figure 46: Histology And Cytology, Denmark, Company share (%), 2010 95
Figure 47: Immuno Chemistry Market, Denmark, Revenue Mix ($m), 2010 97
Figure 48: Immuno Chemistry Market, Denmark, Segment Contribution (%), 2010 98
Figure 49: Immuno Chemistry, Denmark, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 100
Figure 50: Immuno Chemistry, Denmark, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 102
Figure 51: Disease Specific Immunochemistry, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 104
Figure 52: Disease Specific Immunochemistry, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 106
Figure 53: Drugs of Abuse / Toxicology, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 108
Figure 54: Drugs of Abuse / Toxicology, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 110
Figure 55: Endocrinology Tests, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 112
Figure 56: Endocrinology Tests, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 114
Figure 57: Therapeutic Drug Monitoring, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 116
Figure 58: Therapeutic Drug Monitoring, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 118
Figure 59: Immunochemistry Analyzers, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 120
Figure 60: Immunochemistry Analyzers, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 122
Figure 61: Immuno Chemistry, Denmark, Company share (%), 2010 125
Figure 62: Infectious Immunology, Market Segmentation 127
Figure 63: Infectious Immunology Market, Denmark, Revenue Mix ($m), 2010 128
Figure 64: Infectious Immunology Market, Denmark, Segment Contribution (%), 2010 129
Figure 65: Infectious Immunology, Denmark, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 130
Figure 66: Infectious Immunology, Denmark, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 132
Figure 67: Infectious Immunology, Denmark, Company share (%), 2010 135
Figure 68: Microbiology Culture, Market Segmentation 137
Figure 69: Microbiology Culture Market, Denmark, Revenue Mix ($m), 2010 138
Figure 70: Microbiology Culture Market, Denmark, Segment Contribution (%), 2010 139
Figure 71: Microbiology Culture, Denmark, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 140
Figure 72: Microbiology Culture, Denmark, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 142



Figure 73: Microbiology Analyzers, Denmark, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 144
Figure 74: Microbiology Analyzers, Denmark, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 146
Figure 75: Microbiology Culture, Denmark, Company share (%), 2010 149
Figure 76: F. Hoffmann-La Roche Ltd., Company Share (%),Denmark In Vitro Diagnostics Market, 2010 151
Figure 77: Siemens Healthcare, Company Share (%),Denmark In Vitro Diagnostics Market, 2010 152
Figure 78: Abbott Laboratories, Company Share (%),Denmark In Vitro Diagnostics Market, 2010 153
Figure 79: Ortho-Clinical Diagnostics Inc., Company Share (%),Denmark In Vitro Diagnostics Market, 2010 154
Figure 80: Beckman Coulter, Inc., Company Share (%),Denmark In Vitro Diagnostics Market, 2010 155
Figure 81: bioMerieux S.A., Company Share (%),Denmark In Vitro Diagnostics Market, 2010 156

Companies mentioned
F. Hoffmann-La Roche Ltd.
Siemens Healthcare
Abbott Laboratories
Ortho-Clinical Diagnostics Inc.
Beckman Coulter, Inc.
bioMerieux S.A.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Sysmex Corporation
Mindray Medical International Limited
Alere Inc.
DiaSorin S.p.A
Qiagen N.V.
BioPorto Diagnostics A/S
Phadia AB
Gen-Probe Incorporated
DIAGNOSTICA STAGO, Inc.
PerkinElmer, Inc.
Thermo Fisher Scientific Inc.
HORIBA, Ltd.
Grifols, S.A.
Hologic, Inc.
Immucor, Inc.
Life Technologies Corporation
BioPorto Diagnostics A/S


Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information
Please verify that the product information is correct and select the format(s) you require.

Denmark In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histolog
y and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Product Formats
Please select the product formats and the quantity you require.

1 User License--USD 2 500.00 Quantity: _____

Site License--USD 5 000.00 Quantity: _____

Corporate License--USD 7 500.00 Quantity: _____

Contact Information
Please enter all the information below in BLOCK CAPITALS

Title: Mr Mrs Dr Miss Ms Prof

First Name: _____________________________ Last Name: __________________________________

Email Address: __________________________________________________________________________

Job Title: __________________________________________________________________________

Organization: __________________________________________________________________________

Address: __________________________________________________________________________

City: __________________________________________________________________________

Postal / Zip Code: __________________________________________________________________________

Country: __________________________________________________________________________

Phone Number: __________________________________________________________________________

Fax Number: __________________________________________________________________________


Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card Card Number: ______________________________________________

Expiry Date __________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms

Please fax this form to:

Europe, Middle East and Africa : + 33 4 37 37 15 56

Asia, Oceania and America : + 1 (805) 617 17 93


Denmark In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Recommandé

Recommandé

Contenu connexe

Plus de ReportLinker.com

Plus de ReportLinker.com (20)

Denmark In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture